Waters Corporation heads into its May 5 Q1 earnings call carrying a significantly elevated short position — one that has been building rapidly even as the stock has broadly stabilised.
Short sellers have grown notably more aggressive in the past month. Short interest has climbed 24% over the last 30 days to 6.1% of the free float, with the sharpest move coming in a single week: an 11.5% jump that pushed the position back toward cycle highs. Borrow conditions remain accessible, with cost to borrow easing over the past week to 0.39% — hardly a sign of a strained lending market. Availability is ample, confirming there is no squeeze dynamic at play. The build, then, looks like deliberate positioning rather than forced covering. Options tell a different story: the put/call ratio at 0.94 is running slightly below its 20-day average of 0.98, about 1.2 standard deviations to the call side — meaning options traders have actually reduced defensive hedging into the print, even as short sellers have added.
The bull and bear cases diverge sharply on where Waters goes from here. Bears have the weight of recent analyst moves behind them: UBS trimmed its price target to $330 from $370 in mid-April while keeping a Neutral rating, and several other firms cut targets in the weeks following the February print, when the stock fell 14% in a single session and extended losses to nearly 16% over the following five days. That was a brutal earnings reaction, and with the stock now at $307 — still well below those analysts' revised targets — the debate is whether the February miss was a one-off or the start of a multi-quarter reset. The bull case rests on the forward EPS growth picture, which ranks in the 99th percentile of the universe on year-over-year increase — a signal that consensus models still expect a meaningful earnings recovery. Barclays reinstated coverage with an Overweight and a $400 target in February, and Guggenheim has maintained its Buy with a $440 target. The mean analyst target near $370 implies roughly 25% upside from current levels, though the Street has been consistently revising that figure lower.
Two directors bought shares in March — Wei Jiang picked up 500 shares at $289 and Rick Fearon added 1,000 at $306 — providing a modest counterweight to the executive selling. CEO Udit Batra sold just over $1 million worth in early March, as did the CFO. Net insider activity over 90 days is technically positive in share terms, but the executive sales were broadly routine in both size and price. BlackRock lifted its position by more than 2.2 million shares in Q1 to a nearly 8% stake, one of the larger institutional additions on record; T. Rowe Price also added significantly. That institutional demand has provided a floor even as the short position expanded.
The May 5 print will test whether Waters can begin closing the gap between a still-bullish forward EPS story and a February quarter that shook analyst confidence across the board.
See the live data behind this article on ORTEX.
Open WAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
